🇪🇸 Spain · EU Public Tender
Suministro de medicamentos exclusivos Upadacitinib (RINVOQ), Risakizumab (SKYRIZI) y Venetoclax (VENCLYXTO). 1ª prórroga P.N.S.P. 12/2021.
🏛️ Servicio Madrileno de Salud, Hospital Universitario La Paz · 📍 Madrid
782 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Abbvie Spain, S.L.U. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.